T1 Protein 367 371 HRPC
T2 Gene 1392 1397  VEGF
T3 Biomarker 1440 1453 dexamethasone
T4 Level 1636 1641 cells
T5 Gene 724 747 glucocorticoid receptor
T7 Protein 1393 1397 VEGF
T8 Condition 781 797 DU145 xenografts
T9 Condition 883 888 tumor
T11 Protein 1199 1203 VEGF
T13 Protein 947 951 VEGF
T14 Biomarker 904 917 Dexamethasone
T15 Gene 826 831  VEGF
T16 Gene 1044 1049  VEGF
T17 Protein 560 573 interleukin-8
T18 Biomarker 1811 1815 IL-8
T19 Gene 1198 1203  VEGF
T21 Condition 141 175 hormone-refractory prostate cancer
T22 Biomarker 764 777 dexamethasone
T23 Intervention 1495 1506 microvessel
T24 Protein 1045 1049 VEGF
T25 Gene 1291 1314 glucocorticoid receptor
T26 Gene 632 637  VEGF
T27 Intervention 858 869 microvessel
T28 Biomarker 575 579 IL-8
T29 Gene 1533 1538  VEGF
T30 Biomarker 1054 1058 IL-8
T31 Gene 441 464 glucocorticoid receptor
T32 Biomarker 45 59 hydrocortisone
T33 Condition 1422 1427 DU145
T34 Gene 1844 1867 glucocorticoid receptor
T35 Protein 1543 1552 IL-8 gene
T36 Biomarker 642 646 IL-8
T38 Biomarker 616 629 dexamethasone
T39 Protein 1344 1356 hypoxia-like
T40 Protein 251 255 HRPC
T41 Protein 550 554 VEGF
T42 Protein 1054 1066 IL-8 protein
T43 Biomarker 836 840 IL-8
T44 Condition 1758 1763 tumor
T45 Biomarker 1245 1258 dexamethasone
T46 Biomarker 956 960 IL-8
T47 Organism 127 135 patients
T48 Gene 946 951  VEGF
T50 Protein 1326 1331 RU486
T51 Level 1636 1640 cell
T52 Level 662 666 cell
T53 Condition 1680 1716 androgen-independent prostate cancer
T55 Protein 1534 1538 VEGF
T57 Condition 781 786 DU145
T58 Condition 1478 1483 tumor
T59 Biomarker 65 78 dexamethasone
T60 Biomarker 1208 1212 IL-8
T61 Gene 514 549 vascular endothelial growth factor 
T62 Protein 177 181 HRPC
T63 Condition 701 706 DU145
T64 Biomarker 1169 1183 hydrocortisone
T65 Gene 1801 1806  VEGF
T66 Protein 836 845 IL-8 gene
T67 Condition 1422 1438 DU145 xenografts
T68 Biomarker 1573 1586 dexamethasone
